JSJohn P. Sundberg

John P. Sundberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John P. Sundberg has a total of 422 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pathology of the intervertebral disks and other spinal lesions in 31 aging inbred mouse strains

    by John P. Sundberg, Paul N. Schofield, Víctor Nacher Garcia, Beth A. Sundberg, Cheryl L. Ackert-Bicknell, Jerrold M. Ward

    In a large-scale aging study of 31 inbred strains of mice, a variety of age-related lesions arose in and around the spine (vertebrae, spinal cord, and adjacent connective and muscle tissues), including lesions of intervertebral disks, vertebrae, muscles, soft tissues, nerves, ganglia, and spinal cord that were either sporadic or strain-specific. In most cases, the mice did not present with obvious clinical signs, as many lesions were mild. Lesions included herniated or displaced intervertebral disk fragments, which appeared to be sporadic in most strains but were common in others. Fibro-osseous lesions of bones were a systemic disease in female mice with no effect on disk disease. Rhabdomyosarcomas were common in A/J mice surrounding the vertebrae but also invaded into the spinal canal, sometimes almost transecting the cord. Lymphomas affected all AKR/J mice, sometimes infiltrating into the spinal canal. Muscular dystrophy of the musculature surrounding the spine, due to mutations in the dysferlin ( Dysf ) gene, was common in A/J and SJL/J mice. Coccygeal hemivertebra was a novel strain-specific lesion only in PL/J mice. Sporadic lesions in and around the spine included hemangiosarcomas, lymphomas (both enlarged lymph nodes and invading in and around the vertebrae), schwannomas, histiocytic sarcomas, poorly differentiated sarcomas, and epidermoid/dermoid cysts. Since these strains have all been sequenced and annotated, polymorphisms in genes known to affect the pathogenesis of some of these lesions will be reported in other publications.

  • Open Access

    Role of Aire and Notch4 allelic mutations in alopecia areata in C3H/HeJ mice

    by Christopher S. Potter, John P. Sundberg, Kathleen Silva


  • Open Access

    Harmonizing mouse anatomy terminology: a common language?

    by Jesús Ruberte, Paul N. Schofield, John P. Sundberg, Sergi Olvera-Maneu, Ana Carretero

    The mouse remains the principal animal model for investigating human diseases due, among other reasons, to its anatomical similarities to humans. Despite its widespread use, the assumption that mouse anatomy is a fully established field with standardized and universally accepted terminology is misleading. Many phenotypic anatomical annotations do not refer to the authority or origin of the terminology used, while others inappropriately adopt outdated or human-centric nomenclature. This inconsistency is further exacerbated by the limited availability of comprehensive anatomical references, often compelling researchers to rely on “do-it-yourself” anatomical interpretations when characterizing disease models—an approach that increases the risk of inaccuracies in the absence of expert anatomical guidance. To address this critical gap, we propose the formation of expert working groups comprising comparative anatomists and disease model developers. These groups would be responsible for systematically reviewing the anatomical literature of each mouse organ system and producing consensus-based terminologies aligned with the Nomina Anatomica Veterinaria (NAV), the authoritative standard for quadrupedal species. Such harmonization efforts would not only improve the consistency and reliability of anatomical descriptions in mouse models but also enhance the integration and interoperability of anatomical data across biomedical ontologies and databases, facilitating more robust data mining and translational research.

  • Errors in pathology: The real world

    by Jerrold M. Ward, Jeffrey C. Wolf, John P. Sundberg

  • Innovative strategies for the discovery of new drugs against androgenetic alopecia

    by Kevin J. McElwee, John P. Sundberg

    Androgenetic alopecia (AGA) is the most common cause of hair loss worldwide. The significant psychological and social impact of AGA continues to drive demand for more effective treatments beyond the limited options currently available. The authors review the key components of AGA pathogenesis, as well as current treatments and therapeutic techniques under development. Innovative strategies for AGA drug discovery are still needed given the significant unmet medical needs and the limited efficacy of both current and emerging treatments. They also outline relevant preclinical models, such as hair follicle cell cultures, 3D spheroids and organoids, follicle explants, and animal models, highlighting their advantages and limitations in AGA research. Finally, the authors summarize the primary objectives in AGA treatment development, including direct hair growth promotion, interference with androgen signaling, and HF rejuvenation, identifying key pathogenesis intervention points for treatment development. Developing better in vitro models, possibly using induced pluripotent stem cell (iPSC) systems, could greatly accelerate drug discovery. Similarly, a superior in vivo model could significantly expedite drug discovery. Near future development research should focus on drug delivery improvements. Longer term, treatments targeting AGA's underlying pathophysiology and promoting HF rejuvenation or true regeneration would provide the most benefit to prospective patients.


  • Open Access

    Invasive cancer and spontaneous regression two weeks after papillomavirus infection

    by Andrea Bilger, Ella T. Ward-Shaw, Denis L. Lee, Renee E. King, Michael A. Newton, Darya Buehler, Kristina A. Matkowskyj, John P. Sundberg, Rong Hu, Paul F. Lambert

    Development of invasive cancer in mammals is thought to require months or years after initial events such as mutation or viral infection. Rarely, invasive cancers regress spontaneously. We show that cancers can develop and regress on a timescale of weeks, not months or years. Invasive squamous cell carcinomas developed in normal adult, immune-competent mice as soon as 2 weeks after infection with mouse papillomavirus MmuPV1. Tumor development, regression or persistence was tissue- and strain-dependent. Cancers in infected mice developed rapidly at sites also prone to papillomavirus-induced tumors and cancers in humans – the throat, anus, and skin – and their frequency was increased in mice constitutively expressing the papillomavirus E5 oncogene, which MmuPV1 lacks. Cancers and dysplasia in the throat and anus regressed completely within 4-8 weeks of infection; however, skin lesions in the ear persisted. T-cell depletion in the mouse showed that regression of throat and anal tumors requires T cells. We conclude that papillomavirus infection suffices for rapid onset of invasive cancer, and persistence of lesions depends on factors including tissue type and host immunity. The speed of these events should promote rapid progress in the study of viral cancer development, persistence, and regression. Summary Graphic:


  • Open Access

    Current Protocols: Alopecia Areata Mouse Models for Drug Efficacy and Mechanism Studies

    by John P. Sundberg, Eddy H. C. Wang, Kevin J. McElwee

    Alopecia areata is the second most common form of hair loss in humans after androgenetic alopecia. Although a variety of animal models for alopecia areata have been described, currently the C3H/HeJ mouse model is the most commonly used and accepted. Spontaneous hair loss occurs in 15%‐25% of older mice in which the lesions wax and wane, similar to the human disease, with alopecia being more common and severe in female mice. Full‐thickness skin grafts from mice with spontaneous alopecia areata to young, normal‐haired, histocompatible mice provide a highly reproducible model with progressive lesions that makes it useful for drug efficacy and mechanism‐based studies. As alopecia areata is a cell‐mediated autoimmune disease, transfer of cultured lymph node cells from affected mice to unaffected, histocompatible recipients also promotes disease development and provides an alternative, nonsurgical protocol. Protocols are presented to produce these models such that they can be used to study alopecia areata and to develop novel drug therapies. © 2024 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1 : Full‐thickness skin grafts to reproducibly induce alopecia areata in C3H/HeJ mice Basic Protocol 2 : Adoptive transfer of cultured lymphoid cells provides a nonsurgical method to induce alopecia areata in C3H/HeJ mice


  • Open Access

    Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorum

    by Thomas J. Sproule, Robert Y. Wilpan, John J. Wilson, Benjamin E. Low, Yudai Kabata, Tatsuo Ushiki, Riichiro Abe, Michael V. Wiles, Derry C. Roopenian, John P. Sundberg

    The Lamc2jeb junctional epidermolysis bullosa (EB) mouse model has been used to demonstrate that significant genetic modification of EB symptoms is possible, identifying as modifiers Col17a1 and six other quantitative trait loci, several with strong candidate genes including dystonin (Dst/Bpag1). Here, CRISPR/Cas9 was used to alter exon 23 in mouse skin specific isoform Dst-e (Ensembl GRCm38 transcript name Dst-213, transcript ID ENSMUST00000183302.5, protein size 2639AA) and validate a proposed arginine/glutamine difference at amino acid p1226 in B6 versus 129 mice as a modifier of EB. Frame shift deletions (FSD) in mouse Dst-e exon 23 (Dst-eFSD/FSD) were also identified that cause mice carrying wild-type Lamc2 to develop a phenotype similar to human EB simplex without dystonia musculorum. When combined, Dst-eFSD/FSD modifies Lamc2jeb/jeb (FSD+jeb) induced disease in unexpected ways implicating an altered balance between DST-e (BPAG1e) and a rarely reported rodless DST-eS (BPAG1eS) in epithelium as a possible mechanism. Further, FSD+jeb mice with pinnae removed are found to provide a test bed for studying internal epithelium EB disease and treatment without severe skin disease as a limiting factor while also revealing and accelerating significant nasopharynx symptoms present but not previously noted in Lamc2jeb/jeb mice.


  • Open Access

    Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in mice

    by Thomas J Sproule, Robert Y Wilpan, Benjamin E Low, Kathleen A Silva, Deepak Reyon, J Keith Joung, Michael V Wiles, Derry C Roopenian, John P Sundberg

    Previous work strongly implicated Collagen 17a1 (Col17a1) as a potent genetic modifier of junctional epidermolysis bullosa (JEB) caused by a hypomorphic mutation (Lamc2jeb) in mice. The importance of the noncollagenous domain (NC4) of COLXVII was suggested by use of a congenic reduction approach that restricted the modifier effect to 2–3 neighboring amino acid changes in that domain. The current study utilizes TALEN and CRISPR/Cas9 induced amino acid replacements and in-frame indels nested to NC4 to further investigate the role of this and adjoining COLXVII domains both as modifiers and primary risk effectors. We confirm the importance of COLXVI AA 1275 S/G and 1277 N/S substitutions and utilize small nested indels to show that subtle changes in this microdomain attenuate JEB. We further show that large in-frame indels removing up to 1482 bp and 169 AA of NC6 through NC1 domains are surprisingly disease free on their own but can be very potent modifiers of Lamc2jeb/jeb JEB. Together these studies exploiting gene editing to functionally dissect the Col17a1 modifier demonstrate the importance of epistatic interactions between a primary disease-causing mutation in one gene and innocuous ‘healthy’ alleles in other genes.